Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App





CT Scans Prove Highly Accurate in Diagnosing COVID-19 Pneumonia and Predicting Death or Need for Intubation

By HospiMedica International staff writers
Posted on 05 Jul 2021
In a new study involving more than 10,000 patients, researchers found that chest computed tomography (CT) was 80% accurate in diagnosing COVID-19 pneumonia and predicting death or the need for intubation.

Given the conflicting data regarding the diagnostic performance of CT for COVID-19 pneumonia, the researchers undertook the STOIC (Study of ThOracic computed tomography In COVID-19) project that aimed to build a dataset of at least 10,000 CT scans from individuals with suspected COVID-19 pneumonia, evaluated during the first wave of the SARS-Cov-2 pandemic in France. More...
The project involved 20 French hospitals that were equipped with multi-detector CT scanners, allowing volumetric high-resolution CT acquisitions of the whole thorax. CT acquisitions were performed without contrast administration except when pulmonary embolism was suspected as a confounding diagnosis to COVID-19 pneumonia at presentation.

Eligible subjects presented at the emergency departments of the hospitals involved between March 1st and April 30th, 2020 and underwent both thoracic CT and RT-PCR for suspected COVID-19 pneumonia. CT images were read blinded to initial reports, RT-PCR, demographic characteristics, clinical symptoms, and outcome. Readers classified CT scans as positive or negative for COVID-19, based on criteria published by the French Society of Radiology. Multivariable logistic regression was used to develop a model predicting severe outcome (intubation or death) at 1-month follow-up in subjects positive for both RT-PCR and CT, using clinical and radiological features.

The researchers found that using predefined criteria and RT-PCR as the reference standard in 10735 subjects with suspected COVID-19 pneumonia, CT diagnostic accuracy for COVID-19 was 80%, which increased to 86% after five days of symptoms. The extent of pneumonia at CT (OR, 3.25) was the best predictor of severe outcome (intubation or death) at one month. The researchers also found that CT diagnostic accuracy was not influenced by reader experience. Thus, the study concluded that using pre-defined criteria, CT reading is not influenced by reader’s experience and helps predict the outcome at one month.



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Gas Consumption Analyzer
Anesthetic Gas Consumption Analyzer
Radiation Safety Barrier
RayShield Intensi-Barrier
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.